Read more

March 25, 2022
1 min read
Save

Top in rheumatology: Surge in specialty drug use, chronic pain in children

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A report published by CVS Health showed that autoimmune treatments accounted for more than half of all specialty drug growth in 2021. It was the top story in rheumatology last week.

Another top story was about a study that found children with chronic pain or rheumatic disease who experienced adverse childhood events — ranging from abuse to chronic stressors such as parental mental illness — had a greater risk for worse “functional disability.”

ArthritisChild_270388215
Source: Adobe Stock

Read these and more top stories in rheumatology below:

Surge in specialty drug use ‘largely driven’ by autoimmune disease

Autoimmune treatments accounted for more than half of all specialty drug growth in 2021, according to a drug trend report released by CVS Health. Read more.

Children who experience adverse childhood events may have worse chronic pain symptoms

Children with chronic pain or rheumatic disease who experience adverse childhood events may be at a greater risk for worse symptoms and “functional disability,” according to data published in Pediatric Rheumatology. Read more.

Food insecurity may influence depression in patients with rheumatoid arthritis

Social determinants of health, including food insecurity, are prevalent among adults with self-reported rheumatoid arthritis, according to a study published in BMC Rheumatology. Read more.

Nintedanib has greater impact on SSc-ILD in patients without cough, dyspnea at baseline

Nintedanib (Ofev, Boehringer Ingelheim) reduces the rate of forced vital capacity decline more significantly in patients with systemic sclerosis-associated interstitial lung disease who reported no dyspnea or cough at baseline, data show. Read more.

Hooked on Rheum with Stanley Cohen, MD

When I was in medical school at the University of Alabama at Birmingham in 1972, it was really the beginning of immunology as a field of study. The immunology group at UAB made significant discoveries such as determining the source of origin of B cells, and we as students were fortunate to be exposed to them in the classroom. Read more.